| Product Code: ETC6554078 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of non-alcoholic steatohepatitis (NASH) biomarkers to Bulgaria in 2024 saw a significant increase in concentration, with top exporting countries being Italy, USA, Sweden, Germany, and the UK. The high Herfindahl-Hirschman Index (HHI) concentration in 2023 intensified to very high levels in 2024, indicating a more consolidated Market Top 5 Importing Countries and Market Competition (HHI) Analysis . Despite the impressive compound annual growth rate (CAGR) of 20.01% from 2020 to 2024, there was a sharp decline in the growth rate from 2023 to 2024 at -79.06%, suggesting a potential shift or consolidation in the Market Top 5 Importing Countries and Market Competition (HHI) Analysis dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Overview |
3.1 Bulgaria Country Macro Economic Indicators |
3.2 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, 2021 & 2031F |
3.3 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Industry Life Cycle |
3.4 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Porter's Five Forces |
3.5 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By Biomarker Type, 2021 & 2031F |
3.6 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of non-alcoholic steatohepatitis (NASH) in Bulgaria |
4.2.2 Rising awareness about the importance of early diagnosis and treatment of NASH |
4.2.3 Technological advancements in biomarker research and development |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for NASH biomarker testing |
4.3.2 High cost associated with biomarker development and commercialization |
4.3.3 Regulatory challenges in bringing new biomarkers to market |
5 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends |
6 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Types |
6.1 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By Biomarker Type |
6.1.1 Overview and Analysis |
6.1.2 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Type, 2021- 2031F |
6.1.3 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Serum Biomarkers, 2021- 2031F |
6.1.4 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Biomarker Panels, 2021- 2031F |
6.1.5 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Fibrosis Biomarkers, 2021- 2031F |
6.1.6 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Imaging Biomarkers, 2021- 2031F |
6.1.7 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market, By End User |
6.2.1 Overview and Analysis |
6.2.2 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Diagnostic Centers, 2021- 2031F |
6.2.4 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenues & Volume, By Others, 2021- 2031F |
7 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Import-Export Trade Statistics |
7.1 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Export to Major Countries |
7.2 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Imports from Major Countries |
8 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Key Performance Indicators |
8.1 Number of NASH cases diagnosed using biomarkers |
8.2 Adoption rate of NASH biomarker testing in healthcare facilities |
8.3 Research and development investment in NASH biomarkers |
8.4 Number of partnerships and collaborations for biomarker development |
8.5 Rate of regulatory approvals for new NASH biomarkers |
9 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Opportunity Assessment |
9.1 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By Biomarker Type, 2021 & 2031F |
9.2 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market - Competitive Landscape |
10.1 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Revenue Share, By Companies, 2024 |
10.2 Bulgaria Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |